(Q43738086)

English

Expression of both estrogen receptor-beta 1 (ER-β1) and its co-regulator steroid receptor RNA activator protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with estrogen receptor-alpha (ER-α)-negative early breast cancer (EB

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Expression of both estrogen receptor-beta 1 (ER-β1) and its co-regulator steroid receptor RNA activator protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with estrogen receptor-alpha (ER-α)-negative early breast cancer (EB (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Leigh C. Murphy

12

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

Y Yan

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

X Li

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

A Blanchard

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

V H C Bramwell

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

K I Pritchard

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

D Tu

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

L Shepherd

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Y Myal

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

C Penner

9

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

P H Watson

10

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

E Leygue

11

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

11 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1986-1993

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

The role of estrogen receptor-β in breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Estrogen receptor-beta and breast cancer: translating biology into clinical practice

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Is oestrogen receptor-beta a predictor of endocrine therapy responsiveness in human breast cancer?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

New insights into estrogen receptor function in human breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Estrogen receptors and proliferation markers in primary and recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

The steroid receptor RNA activator protein is recruited to promoter regions and acts as a transcriptional repressor

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Chlamydial protease CT441 interacts with SRAP1 co-activator of estrogen receptor alpha and partially alleviates its co-activation activity.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada--Clinical Trials Group Trial, MA.12)

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

A 50-gene intrinsic subtype classifier for prognosis and prediction of benefit from adjuvant tamoxifen

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Assessment of multiple different estrogen receptor-beta antibodies for their ability to immunoprecipitate under chromatin immunoprecipitation conditions.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomas

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Estrogen receptor-α and estrogen receptor-β in the uterine vascular endothelium during pregnancy: functional implications for regulating uterine blood flow.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Mechanisms of action of estrogen receptors in vascular cells: relevance for menopause and aging.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

The complex role of estrogens in inflammation.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Predicting Response to Endocrine Therapy in Human Breast Cancer: A Hypothesis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT132

21 January 2018

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/S0140-6736(11)60993-8

Identifiers

10.1093/ANNONC/MDT132

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43738086&oldid=2102940994"